Secondary relevance to vitamin D This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.
This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.
Why this paper is included
Supporting source evidence:
No significant differences were observed in β-CTX, 25(OH)D, ALP, PTH, or Ca levels between groups (all P>0.05).
Source: Differences in BTMs between GHD and ISS groups. View original paper
Relevance classification does not establish study quality, causation or editorial approval.
Study design Cross-sectional study.
Cross-sectional study
Examines a population at a particular point in time.
Meta-analysis unclear · Blinding unclear / not reported · Human research reported
How this paper was classified
Automatic source-based classification; awaiting editorial verification. This is not a quality score.
A cross-sectional study was conducted, enrolling 76 children aged 3 to 11 years with short stature (37 in the GHD group and 39 in the ISS group).
Source: Abstract.
A cross-sectional study was conducted, enrolling 76 children aged 3 to 11 years with short stature (37 in the GHD group and 39 in the ISS group).
Source: Abstract.
What the study types mean
- Systematic review
- Uses explicit methods to identify, assess and summarise research on a defined question.
- Scoping review
- Maps the extent and characteristics of research on a topic.
- Narrative review
- Discusses existing research; systematic-review methods have not been established by this classification.
- Review / evidence synthesis
- Reviews existing research; the exact review methods need further assessment.
- Randomised controlled trial
- Assigns participants or groups to comparison interventions by chance.
- Non-randomised intervention study
- Examines an intervention without random allocation.
- Cohort study
- Examines exposures and outcomes over time within a defined group.
- Case-control study
- Compares people with an outcome against people without it, examining exposures.
- Cross-sectional study
- Examines a population at a particular point in time.
- Observational study
- Observes exposures and outcomes without assigning the exposure; the subtype is not established here.
- Case report
- Describes an individual case.
- Case series
- Describes a group of individual cases.
- Secondary analysis
- Analyses existing study data; this paper is not automatically another independent trial.
- Laboratory study
- Investigates biological processes in a laboratory setting.
- Qualitative study
- Examines experiences or meanings using qualitative methods.
- Genetic instrumental-variable study
- Uses genetic variation as an instrument to investigate relationships; this is not a randomised treatment trial.
- Study protocol
- Describes planned methods and is not evidence that the planned study has reported results.
- Multiple reported designs
- More than one design is explicitly reported; examine the supporting methods.
- Study design awaiting verification
- The available source does not establish a sufficiently clear study design.
Meta-analysis combines numerical results from studies. Blinding describes who was unaware of treatment allocation. Neither is a separate quality grade. Study design, vitamin D relevance and document format are independent filters.
Abstracts
Serum osteocalcin as a novel biomarker for differentiating growth hormone deficiency from idiopathic short stature
Cross-sectional study · Frontiers in Endocrinology · 2026
Original publication title
Serum osteocalcin as a novel biomarker for differentiating growth hormone deficiency from idiopathic short stature
Copyright © 2026 Wang, Zhou, Wang, Ma, Chen, Yang, Zheng and Wang.
Original publication · Publisher record · CC BY 4.0
Source wording retained. Formatting, section navigation and display-title punctuation adapted for this research record.
At a glance
Abstract: What objectives does the paper state?
To evaluate the diagnostic value of bone turnover markers in distinguishing GHD from ISS.
Source: ObjectiveAbstract: What methods does the paper describe?
A cross-sectional study was conducted, enrolling 76 children aged 3 to 11 years with short stature (37 in the GHD group and 39 in the ISS group). Clinical data including height, weight, bone age, Insulin-like Growth Factor 1(IGF-1), and Peak Growth Hormone (GHP) levels were collected. Eight bone turnover markers were measured: Osteocalcin (OC), β-C-terminal telopeptide of type I collagen (β-CTX), 25-Hydroxyvitamin D (25(OH)D), Vitamin D (VitD), Alkaline Phosphatase (ALP), Parathyroid Hormone (PTH), serum Calcium (Ca), and serum Phosphorus (P). Nonparametric tests were used for intergroup comparisons.
Logistic regression and Receiver Operating Characteristic (ROC) curve analyses were performed to assess diagnostic efficacy, and Spearman correlation analysis was employed for correlation evaluation.
Source: MethodsAbstract: Results
The OC level in the GHD group was significantly lower than that in the ISS group (P < 0.001), while serum P was higher in the GHD group (P < 0.05). Multivariate analysis identified OC as an independent discriminative factor (OR = 182.585, P < 0.001). ROC curve analysis revealed that OC had an area under the curve (AUC) of 0.949, At a cutoff of 1.026 ng/mL, sensitivity was 86.49% and specificity was 100%. Correlation analysis indicated a positive association between OC levels and GHP (r = 0.6, P < 0.05).
Source: ResultsAbstract: Conclusion
Serum OC shows high diagnostic value for distinguishing GHD from ISS, demonstrating significant clinical utility.
Source: ConclusionAuthors’ abstract
Background
The differentiation between Growth Hormone Deficiency (GHD) and Idiopathic Short Stature (ISS) primarily relies on the growth hormone stimulation test (GHST),which is invasive and can cause adverse effects.
Objective
To evaluate the diagnostic value of bone turnover markers in distinguishing GHD from ISS.
Methods
A cross-sectional study was conducted, enrolling 76 children aged 3 to 11 years with short stature (37 in the GHD group and 39 in the ISS group). Clinical data including height, weight, bone age, Insulin-like Growth Factor 1(IGF-1), and Peak Growth Hormone (GHP) levels were collected. Eight bone turnover markers were measured: Osteocalcin (OC), β-C-terminal telopeptide of type I collagen (β-CTX), 25-Hydroxyvitamin D (25(OH)D), Vitamin D (VitD), Alkaline Phosphatase (ALP), Parathyroid Hormone (PTH), serum Calcium (Ca), and serum Phosphorus (P). Nonparametric tests were used for intergroup comparisons.
Logistic regression and Receiver Operating Characteristic (ROC) curve analyses were performed to assess diagnostic efficacy, and Spearman correlation analysis was employed for correlation evaluation.
Results
The OC level in the GHD group was significantly lower than that in the ISS group (P < 0.001), while serum P was higher in the GHD group (P < 0.05). Multivariate analysis identified OC as an independent discriminative factor (OR = 182.585, P < 0.001). ROC curve analysis revealed that OC had an area under the curve (AUC) of 0.949, At a cutoff of 1.026 ng/mL, sensitivity was 86.49% and specificity was 100%. Correlation analysis indicated a positive association between OC levels and GHP (r = 0.6, P < 0.05).
Conclusion
Serum OC shows high diagnostic value for distinguishing GHD from ISS, demonstrating significant clinical utility.
Publication and source details
Original title: Serum osteocalcin as a novel biomarker for differentiating growth hormone deficiency from idiopathic short stature
Yuling Wang; Huanzhen Zhou; Hongye Wang; Jianying Ma; Xingyu Chen; Hongmei Yang; Hongcun Zheng; Aiping Wang
Frontiers in Endocrinology · 2026
* Correspondence: Aiping Wang, 980291119@qq.com†These authors have contributed equally to this work
Repository JATS snapshot; version as supplied
Source retrieved: 2026-11-10T23:45:41.013233+00:00
DOI: 10.3389/fendo.2026.1745971 · PMC13013015